AXOVIA THERAPEUTICS LTD

Active London

Research and experimental development on biotechnology

8 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
A

AXOVIA THERAPEUTICS LTD

Research and experimental development on biotechnology

Founded 8 Mar 2023 Active London, England 8 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
Accounts Submitted 23 Apr 2026 Next due 30 Sept 2026 4 months remaining
Confirmation Submitted 9 Mar 2026 Next due 21 Mar 2027 10 months remaining
Net assets £271K £1M 2024 year on year
Total assets £6M £4M 2024 year on year
Total Liabilities £5M £5M 2024 year on year
Charges 3
3 satisfied

Contact & Details

Contact

Registered Address

78 Pall Mall London SW1Y 5ES England

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for AXOVIA THERAPEUTICS LTD (14715294), an active life sciences and medical technology company based in London, England. Incorporated 8 Mar 2023. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2023–2024)

Cash in Bank

N/A

Net Assets

£271.02k

Decreased by £1.48M (-85%)

Total Liabilities

£5.41M

Increased by £5.25M (+3297%)

Turnover

N/A

Employees

8

Increased by 6 (+300%)

Debt Ratio

95%

Increased by 87 (+1088%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

3 Allotments 196,976 Shares £6896.41m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
21 Oct 202540,239£40.239£0.001
21 Oct 2025130,487£5.79m£44.35
16 Oct 202326,250£6890.63m£263k

Officers

Officers

3 active
Status
Balfour, Robert Henry, DrDirectorBritishEngland4624 May 2023Active
Goldsmith, Bruce AokiDirectorAmericanUnited States603 Feb 2025Active
Safarian, AlekDirectorAustralianUnited States618 Mar 2023Active

Shareholders

Shareholders (7)

Alsa Ventures I Scsp
42.4%
183,750
Alsa Ventures I Scsp
29.0%
125,440

Persons with Significant Control

Persons with Significant Control (2)

2 Active

Mr Alek Safarian

Australian

Active
Notified 8 Mar 2023
Residence United States
DOB October 1964
Nature of Control
  • Ownership Of Shares 50 To 75 Percent
  • Voting Rights 50 To 75 Percent
  • Right To Appoint And Remove Directors

Alsa Ventures I Scsp

Luxembourg

Active
Notified 12 May 2023
Nature of Control
  • Ownership Of Shares 75 To 100 Percent

Group Structure

Group Structure

AXOVIA THERAPEUTICS LTD Current Company

Charges

Charges

3 satisfied

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
23 Apr 2026AccountsAnnual accounts made up to 31 Dec 2025
9 Mar 2026Confirmation StatementConfirmation statement made on 7 Mar 2026 with updates
6 Mar 2026MortgageMortgage Satisfy Charge Full
6 Mar 2026MortgageMortgage Satisfy Charge Full
1 Dec 2025IncorporationMemorandum Articles
23 Apr 2026 Accounts

Annual accounts made up to 31 Dec 2025

9 Mar 2026 Confirmation Statement

Confirmation statement made on 7 Mar 2026 with updates

6 Mar 2026 Mortgage

Mortgage Satisfy Charge Full

6 Mar 2026 Mortgage

Mortgage Satisfy Charge Full

1 Dec 2025 Incorporation

Memorandum Articles

Recent Activity

Latest Activity

Annual accounts made up to 31 Dec 2025

2 weeks ago on 23 Apr 2026

Confirmation statement made on 7 Mar 2026 with updates

2 months ago on 9 Mar 2026

Mortgage Satisfy Charge Full

2 months ago on 6 Mar 2026

Mortgage Satisfy Charge Full

2 months ago on 6 Mar 2026

Memorandum Articles

5 months ago on 1 Dec 2025